Healthcare Supply Chains: Building Strategic Resilience in 2024

Healthcare supply chains face mounting pressures from geopolitical tensions, supplier concentration, and demand volatility. RSM US LLP's strategic framework addresses the structural vulnerabilities exposed during recent global disruptions, emphasizing the need for diversified sourcing, real-time visibility, and collaborative planning across manufacturers, distributors, and providers. This analysis examines how healthcare organizations can transition from reactive crisis management to proactive resilience by implementing segmented strategies tailored to different product categories—from critical life-saving medications to routine medical supplies.

The healthcare sector's dependence on concentrated supplier networks creates single points of failure that can cascade across regional and national markets. Strategic paths to resilience include nearshoring key components, establishing redundant cold-chain infrastructure, and implementing demand-sensing technologies that reduce inventory bulges while maintaining service levels. Organizations that adopt these practices position themselves to navigate future disruptions while maintaining continuity of care.

For supply chain professionals, this represents a pivot from cost minimization to risk-adjusted optimization. The implications extend beyond logistics—they encompass procurement strategy, capital allocation, and stakeholder governance. Healthcare systems must evaluate their supply chain maturity against best practices in resilience, supplier management, and end-to-end visibility to ensure they can fulfill critical patient care commitments.